Page last updated: 2024-09-05

lapatinib and ast 1306

lapatinib has been researched along with ast 1306 in 2 studies

Compound Research Comparison

Studies (lapatinib)	Trials (lapatinib)	Recent Studies (post-2010) (lapatinib)	Studies (ast 1306)	Trials (ast 1306)	Recent Studies (post-2010) (ast 1306)
1,919	305	1,442	18	2	17

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bai, F; Jiang, H; Li, H; Liu, H; Liu, L; Liu, X; Tong, L; Wang, X; Xie, H; Zhao, Z; Zhou, W	1
Baltazar, F; Barbosa, AM; Cardoso-Carneiro, D; Cury, FP; de Paula, FE; Evangelista, AF; Granja, S; Longatto-Filho, A; Marques, F; Martinho, O; Miranda-Gonçalves, V; Moreira, MA; Reis, RM; Scapulatempo-Neto, C; Silva-Oliveira, R; Zanon, M	1

Other Studies

2 other study(ies) available for lapatinib and ast 1306

Article	Year
Discovery of novel selective inhibitors for EGFR-T790M/L858R. Bioorganic & medicinal chemistry letters, 2012, Feb-01, Volume: 22, Issue:3 Topics: Catalytic Domain; Cell Line, Tumor; Cell Proliferation; Drug Discovery; ErbB Receptors; Humans; Inhibitory Concentration 50; Models, Molecular; Molecular Structure; Mutation; Protein Kinase Inhibitors	2012
HER Family Receptors are Important Theranostic Biomarkers for Cervical Cancer: Blocking Glucose Metabolism Enhances the Therapeutic Effect of HER Inhibitors. Theranostics, 2017, Volume: 7, Issue:3 Topics: Acrylamides; Adenocarcinoma; Antimetabolites; Antineoplastic Agents; Biomarkers, Tumor; Diagnostic Tests, Routine; Drug Resistance, Neoplasm; ErbB Receptors; Female; Glucose; Humans; Lapatinib; Quinazolines; Theranostic Nanomedicine; Therapeutic Uses; Uterine Cervical Neoplasms	2017

Article

Year

Discovery of novel selective inhibitors for EGFR-T790M/L858R.

Bioorganic & medicinal chemistry letters, 2012, Feb-01, Volume: 22, Issue:3

Topics: Catalytic Domain; Cell Line, Tumor; Cell Proliferation; Drug Discovery; ErbB Receptors; Humans; Inhibitory Concentration 50; Models, Molecular; Molecular Structure; Mutation; Protein Kinase Inhibitors

2012

HER Family Receptors are Important Theranostic Biomarkers for Cervical Cancer: Blocking Glucose Metabolism Enhances the Therapeutic Effect of HER Inhibitors.

Theranostics, 2017, Volume: 7, Issue:3

Topics: Acrylamides; Adenocarcinoma; Antimetabolites; Antineoplastic Agents; Biomarkers, Tumor; Diagnostic Tests, Routine; Drug Resistance, Neoplasm; ErbB Receptors; Female; Glucose; Humans; Lapatinib; Quinazolines; Theranostic Nanomedicine; Therapeutic Uses; Uterine Cervical Neoplasms

2017